AMPH Amphstar Pharmaceuticals, Inc.
$25.91 +2.13%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+2.13%
YTD
+0.30%
P/E
13.73
P/B
1.56
ROE
10.1%
Div yield
—
Beta
0.56
Market cap
$1.1B
RSI (14)
63
Next earnings
Nov 4, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$25.54
Close
$25.91
VWAP (n/a)
—
Day high
$26.08
Day low
$25.03
Volume
469K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?
Yahoo Finance · Oct 6
3 Reasons to Avoid AMPH and 1 Stock to Buy Instead
Yahoo Finance · Sep 24
Amphastar Pharmaceuticals (NASDAQ:AMPH): Strongest Q2 Results from the Generic Pharmaceuticals Group
Yahoo Finance · Sep 17
Amphastar Pharmaceuticals (AMPH) Rebounds In Focus, Is It Slightly Overvalued?
Yahoo Finance · Sep 6
Amphastar Pharmaceuticals (AMPH) Stock Looks Cheap With Earnings Doing The Heavy Lifting
Yahoo Finance · Sep 5
Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference
Yahoo Finance · Sep 1
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 6, 2026 View → 8-K Aug 6, 2026 View → 8-K Jul 13, 2026 View → 8-K Jul 8, 2026 View → 8-K Jun 3, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell AMPH. Try it in the Lab to size a position and see the risk.